ArticleOncotarget2015
A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies.
Mary E Irwin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it
ArticleOncotarget2015
Mary E Irwin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.